These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 16775950)

  • 1. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
    Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
    Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
    Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
    Şimşek H; Tarhan G; Cesur S
    Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs].
    Sayğan MB; Ocak F; Cesur S; Tarhan G; Ceyhan I; Gümüişlü F; Beker G; Güner U; Coşkun E
    Mikrobiyol Bul; 2007 Jul; 41(3):403-9. PubMed ID: 17933251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
    Toungoussova OS; Mariandyshev AO; Bjune G; Caugant DA; Sandven P
    Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):202-6. PubMed ID: 15742171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility tests to second line drugs and re-treatment of tuberculosis revisiting early experiences.
    de Kantor IN; Barrera L
    Medicina (B Aires); 2007; 67(3):231-7. PubMed ID: 17628909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
    Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
    Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of critical concentrations of second-line anti-tuberculosis drugs with clinical and microbiological relevance.
    Kam KM; Sloutsky A; Yip CW; Bulled N; Seung KJ; Zignol M; Espinal M; Kim SJ
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):282-8. PubMed ID: 20132618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
    Verma JS; Nair D; Rawat D; Manzoor N
    Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance rates to major anti-tuberculosis drugs in Mycobacterium tuberculosis strains isolated from seven different regions of Turkey in 2003-2006 period].
    Uçar E; Kiliç A; Ceyhan I; Yilmaz S; Kiliç S; Tarhan G; Simşek H; Güllü U; Başustaoğlu AC
    Mikrobiyol Bul; 2010 Jan; 44(1):11-9. PubMed ID: 20455394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.
    Martin A; von Groll A; Fissette K; Palomino JC; Varaine F; Portaels F
    J Clin Microbiol; 2008 Dec; 46(12):3952-6. PubMed ID: 18945838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nitrate reductase assay for rapid detection of resistance to second-line drugs in Mycobacterium tuberculosis in a tertiary care hospital.
    Visalakshi P; Arora J; Behera D
    Diagn Microbiol Infect Dis; 2010 Nov; 68(3):236-40. PubMed ID: 20851548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The resistance to major antituberculous drugs of Mycobacterium tuberculosis strains isolated from the respiratory system specimens of tuberculosis patients in Duzce, Turkey.
    Ozturk CE; Balbay OA; Kaya D; Ceyhan I; Bulut I; Sahin I
    Jpn J Infect Dis; 2005 Feb; 58(1):47-9. PubMed ID: 15728994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of extensively drug-resistant tuberculosis in Vladimir and Orel regions, Russia.
    Punga VV; Jakubowiak WM; Danilova ID; Somova TR; Volchenkov GV; Kazionnyy BY; Nemtsova ES; Kiryanova EV; Kourbatova EV
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1309-12. PubMed ID: 19793439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System.
    Rodrigues C; Jani J; Shenai S; Thakkar P; Siddiqi S; Mehta A
    Int J Tuberc Lung Dis; 2008 Dec; 12(12):1449-55. PubMed ID: 19017456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.